Full text is available at the source.
Abstract
Obstructive sleep apnea (OSA) is highly associated with obesity and cardiovascular complications.
- Patients with OSA may experience significant cardiovascular issues.
- Treatment with GLP-1 agonists is being evaluated for its effects on cardiovascular outcomes.
- Continuous Positive Airway Pressure (CPAP) is commonly used for managing OSA.
- Comparative outcomes between GLP-1 agonists and CPAP in OSA patients are under investigation.
Simplified